Literature DB >> 20486915

Patient willingness to pay for a kidney for transplantation.

D K Herold1.   

Abstract

While kidney transplantation is the most cost-effective treatment available for end-stage renal disease (ESRD) and affords patients with the best quality of life, the current supply of kidneys does not meet the demand. A potential solution to increasing the supply is to compensate living donors for a kidney. The purpose of this study was to describe ESRD patient willingness to pay for a kidney. Using a self-administered survey, 107 patients in 31 U.S. states completed the survey. The quantitative method and descriptive survey design employed descriptive, correlational, nonparametric and multivariate statistical tests to evaluate the data. Of participants, 78.5% were willing to pay for a kidney; there were significant correlations between gender, health status, household income, preferred source of a kidney and willingness to pay. Men, patients with poor and fair health status and those with household incomes > or =$50,000 were more willing to pay. Step-wise regression analysis found price and doctor's influence accounting for 52% of variance in willingness to pay. As price increased and doctor's opinion mattered, willingness to pay increased. This study supports development of additional studies with larger sample sizes and patients on kidney transplant waiting lists.

Entities:  

Mesh:

Year:  2010        PMID: 20486915     DOI: 10.1111/j.1600-6143.2010.03113.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  3 in total

Review 1.  Incentives for organ donation: proposed standards for an internationally acceptable system.

Authors:  Arthur J Matas; Sally Satel; Stephen Munn; Janet Radcliffe Richards; Angeles Tan-Alora; Frederike J A E Ambagtsheer; Micheal D H Asis; Leo Baloloy; Edward Cole; Jeff Crippin; David Cronin; Abdallah S Daar; James Eason; Richard Fine; Sander Florman; Richard Freeman; John Fung; Wulf Gaertner; Robert Gaston; Nasrollah Ghahramani; Ahad Ghods; Michelle Goodwin; Thomas Gutmann; Nadey Hakim; Benjamin Hippen; Ajit Huilgol; Igal Kam; Arlene Lamban; Walter Land; Alan Langnas; Reynaldo Lesaca; Gary Levy; RoseMarie Liquette; William H Marks; Charles Miller; Enrique Ona; Glenda Pamugas; Antonio Paraiso; Thomas G Peters; David Price; Gurch Randhawa; Alan Reed; Keith Rigg; Dennis Serrano; Hans Sollinger; Sankaran Sundar; Lewis Teperman; Gert van Dijk; Willem Weimar; Romina Danguilan
Journal:  Am J Transplant       Date:  2011-12-17       Impact factor: 8.086

2.  Kidneys for Sale: Empirical Evidence From Iran.

Authors:  Tannaz Moeindarbari; Mehdi Feizi
Journal:  Transpl Int       Date:  2022-06-24       Impact factor: 3.842

3.  Cost-benefit analysis of kidney transplant in patients with chronic kidney disease: a case study in Iran.

Authors:  Farzaneh Abdi; Cyrus Alinia; Ali Taghizadeh Afshari; Hasan Yusefzadeh
Journal:  Cost Eff Resour Alloc       Date:  2022-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.